Showing 241-250 of 664 results for "".
Dupilumab For the Management of Pembrolizumab-induced Rash: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dupilumab-for-the-management-of-pembrolizumab-induced-rash-a-case-report/23841/A Long View: Conceptions of Atopic Dermatitis Through the Ages
https://practicaldermatology.com/topics/general-topics/a-long-view-conceptions-of-atopic-dermatitis-through-the-ages/21261/Is Irritable Bowel Linked to Irritable Skin?
https://practicaldermatology.com/columns/clinical-focus-1/is-irritable-bowel-linked-to-irritable-skin/23324/Exploring irritable bowel syndrome’s link to dermatologic conditions.Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.Physician Spotlight: Adam J. Friedman, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-adam-j-friedman-md-1/23614/New In My Practice: Cosmeceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceuticals-4/24019/DefenAge 360-Rejuvenation Nail Root SerumThe Landscape for Vitiligo: An Interview with Larry Green, MD
https://practicaldermatology.com/topics/pigmentary-disorders/the-landscape-for-vitiligo-an-interview-with-larry-green-md/24209/Practical Dermatology® Chief Medical Editor Neal Bhatia, MD, FAAD, talked with Larry Green, MD, a board-certified dermatologist in private practice in Rockville, Maryland, about the latest in vitiligo treatment and what practitioners can tell their patients about recent advances in treatment for thiNew Medicare Cards Are Coming: Be Prepared
https://practicaldermatology.com/topics/practice-management/new-medicare-cards-are-coming-be-prepared/20642/The Medicare Beneficiary Identifier (MBI) will replace the existing Social Security-based Health Insurance Claim Number (HICN). Here's what you need to know.Impetigo: An Unconventional Case Report
https://practicaldermatology.com/topics/rare-disease/impetigo-an-unconventional-case-report/26246/Mauri Hart, a medical student at the Oklahoma State University College of Osteopathic Medicine, takes a look at a unique case study, and tests the reader's knowledge of impetigo.Easing Further Down The Road: Getting Comfortable with MIPS
https://practicaldermatology.com/topics/practice-management/easing-further-down-the-road-getting-comfortable-with-mips/20715/Part two of a three-part series on the MIPS “pick-your-pace” transition.